NEW WEBINAR May 22 | Biomarker Legislation Decoded for Health Plans | Sign Up »           NEW WEBINAR May 22 | Biomarker Legislation Decoded for Health Plans | Sign Up »          NEW WEBINAR May 22 | Biomarker Legislation Decoded for Health Plans | Sign Up »

David brings 25 years of healthcare experience and a record of entrepreneurial leadership to his role as executive chairman. Having joined InformedDNA in 2007 as CEO, David led the company’s transformation from the first national telehealth genetic counseling services provider to becoming the first mover in the now rapidly growing fields of genetic testing utilization management and applied genomics solutions. To fuel the company’s growth, David orchestrated three rounds of venture capital funding and, in 2019, a majority recapitalization. He was previously founder/CEO of The Nixon Group, a marketing communications firm acquired by Interpublic Group [NYSE: IPG] in 2002. David serves on the boards of Foundation Fighting Blindness, American Council on Exercise (ACE), and Florida Venture Education Foundation, and is director emeritus for Facing Our Risk of Cancer Empowered (FORCE). The through-line for his career has been ensuring that people have access to accurate expert information to make their own well-informed decisions, which he continues at InformedDNA.

×